Correction
==========

Following the publication of our article \[[@B1]\], we noticed an error regarding the dosage of vitamin B12. In the manuscript, we reported that the daily dosage of vitamin B12 would be 0.4 mg, when in fact the dosage of vitamin B12 used in the B-VITAGE trial is 0.5 mg per day.

In the abstract:

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B~12~(0.4 mg), B~6~(25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

Should read

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B~12~(0.5 mg), B~6~(25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

In the \"Intervention and Blinding\" section:

Eligible participants will be randomly allocated to treatment with citalopram plus 400 μg vitamin B~12~, 2 mg folic acid and 25 mg B~6~or citalopram plus placebo.

Should read

Eligible participants will be randomly allocated to treatment with citalopram plus 500 μg vitamin B~12~, 2 mg folic acid and 25 mg B~6~or citalopram plus placebo.
